Alpha 1 Antitrypsin Deficiency

Explore clinical trials studying Alpha 1 Antitrypsin Deficiency. Study availability and eligibility vary by location and protocol.

5 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Alpha 1 Antitrypsin Deficiency trial results

Recruiting

NCT07431112

Conditions: Alpha 1 Antitrypsin Deficiency, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: Clinical Study Center Melbourne, Australia

Clinical Study Center 1 Tbilisi, Georgia

Clinical Study Center 2 Tbilisi, Georgia

Clinical Study Center Cambridge, United Kingdom

Recruiting

NCT07555483

Conditions: Alpha 1 Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: GC2501 Study Site 106 Birmingham, Alabama, United States

GC2501 Study Site 102 Phoenix, Arizona, United States

GC2501 Study Site 107 Scottsdale, Arizona, United States

GC2501 Study Site 100 Los Angelas, California, United States

View all 22 locations

Enrolling by Invitation

NCT00884455

Conditions: Alpha 1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: University of Florida Gainesville, Florida, United States

Completed

NCT01669421

Conditions: Alpha 1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Division of Pulmonary and Critical Care, Human Reseach, U of Miami Miami, Florida, United States

Completed

NCT01832220

Conditions: AATD, Alpha 1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Arizona Health Sciences Center Tucson, Arizona, United States

University of California - San Francisco San Francisco, California, United States

National Jewish Health Denver, Colorado, United States

Yale University New Haven, Connecticut, United States